No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs148273002 |
chr14:21652607-21652608 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs546680978 |
chr14:21652620-21652621 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs182583371 |
chr14:21652649-21652650 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs538427902 |
chr14:21652740-21652741 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs552377369 |
chr14:21652785-21652786 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs569042491 |
chr14:21652793-21652794 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs12436835 |
chr14:21652837-21652838 |
Flanking Active TSS Weak transcription Enhancers
|
lncRNA
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
8 |
rs77980562 |
chr14:21652838-21652839 |
Flanking Active TSS Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs12431416 |
chr14:21652897-21652898 |
Flanking Active TSS Weak transcription Enhancers
|
lncRNA
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
10 |
rs12434234 |
chr14:21652934-21652935 |
Flanking Active TSS Weak transcription Enhancers
|
lncRNA
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
11 |
rs553937967 |
chr14:21652935-21652936 |
Flanking Active TSS Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs548830406 |
chr14:21652948-21652949 |
Flanking Active TSS Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs117490583 |
chr14:21653003-21653004 |
Enhancers Weak transcription Flanking Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs186563492 |
chr14:21653091-21653092 |
Enhancers Weak transcription Flanking Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs576663331 |
chr14:21653096-21653097 |
Enhancers Weak transcription Flanking Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs542497389 |
chr14:21653115-21653116 |
Enhancers Weak transcription Flanking Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs562380047 |
chr14:21653133-21653134 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs77213511 |
chr14:21653147-21653148 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs559186048 |
chr14:21653171-21653172 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs546640382 |
chr14:21653188-21653189 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs559970758 |
chr14:21653205-21653206 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs532270104 |
chr14:21653215-21653216 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs552075338 |
chr14:21653220-21653221 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs192330194 |
chr14:21653240-21653241 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs537652332 |
chr14:21653242-21653243 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs548040429 |
chr14:21653292-21653293 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs73575703 |
chr14:21653325-21653326 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
28 |
rs141134293 |
chr14:21653355-21653356 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs118124541 |
chr14:21653359-21653360 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs554163996 |
chr14:21653374-21653375 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs147355914 |
chr14:21653401-21653402 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs139540859 |
chr14:21653428-21653429 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs185523550 |
chr14:21653438-21653439 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs576672139 |
chr14:21653449-21653450 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs553821871 |
chr14:21653493-21653494 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs114369913 |
chr14:21653500-21653501 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs188732171 |
chr14:21653544-21653545 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs200823512 |
chr14:21653598-21653599 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs36098578 |
chr14:21653600-21653601 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs12434619 |
chr14:21653649-21653650 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs570045038 |
chr14:21653666-21653667 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs376674862 |
chr14:21653667-21653668 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs57894855 |
chr14:21653688-21653689 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs560136572 |
chr14:21653747-21653748 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs532105024 |
chr14:21653775-21653776 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs542241367 |
chr14:21653806-21653807 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
47 |
rs368039992 |
chr14:21653807-21653808 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs28733840 |
chr14:21653842-21653843 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
49 |
rs543097219 |
chr14:21653864-21653865 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs562452894 |
chr14:21653915-21653916 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|